Going Public Attorney • Wellesley, Massachusetts

Going Public Attorney in Wellesley

Planning to take your company public? Our Wellesley-based attorneys specialize in IPOs, direct listings, SPAC mergers, and alternative paths to public markets for companies across Finance, Professional Services, Healthcare.

Selective M&A Practice
Personal Attention
Managing Partner on Every Deal

What We Do

Our managing partner provides selective ipo & going public law counsel to clients in Wellesley and nationwide, including:

  • Traditional IPOs and underwritten offerings
  • Direct listings and direct IPOs
  • SPAC business combinations
  • Reverse mergers and shell company transactions
  • OTCQB and OTCQX listings
  • Regulation A Tier 2 offerings (mini-IPOs)
  • Exchange listing applications (NYSE, NASDAQ)
  • Corporate governance and board structuring

Who We Serve

We engage selectively with capitalized founders and investors in Wellesley and nationwide:

  • Growth companies ready for public markets
  • Private equity-backed portfolio companies
  • Mature private companies seeking liquidity
  • Foreign companies seeking U.S. listings
  • Pre-IPO companies building infrastructure
  • Companies considering alternatives to traditional IPOs

M&A Market: Wellesley & the Boston Metro

Boston is the global epicenter of biotech and life sciences M&A, with Kendall Square and the Route 128 corridor housing the densest concentration of biotech companies outside San Francisco. Beyond life sciences, the region drives significant deal activity in financial technology, education technology, and defense contracting. The region's deep research university ecosystem (MIT, Harvard, Tufts) produces a steady stream of spinoff companies ripe for acquisition.

Top M&A Sectors Near Wellesley

  • Biotech & Pharma
  • Financial Technology
  • Education Technology
  • Healthcare IT
  • Defense & Cybersecurity

Deal Environment

Boston's biotech-heavy deal market means acquirers often face complex IP due diligence involving university licenses, clinical trial data, and FDA regulatory considerations. Competition from large pharma strategic acquirers can push valuations higher for promising targets.

Why Acquire in the Boston Area

Boston's concentration of world-class research institutions and highly educated workforce creates a self-reinforcing ecosystem where acquired companies can access talent, partnerships, and capital unavailable in other markets.

Massachusetts Legal Considerations

Massachusetts enacted the Noncompetition Agreement Act in 2018, limiting non-competes to 12 months and requiring garden leave pay - buyers must evaluate existing employee agreements during due diligence as many pre-2018 agreements may now be unenforceable.

"Going public changes everything about how you operate. The reporting obligations, the insider trading rules, the proxy requirements. Companies that aren't prepared for life as a public company shouldn't be rushing to get there."

Alex Lubyansky, Managing Partner On readiness for public company obligations

Massachusetts Legal Considerations for IPO & Going Public Law

Non-Compete Laws

Restricted with 12-month cap and garden leave requirement. Sale-of-business exception.

Filing Requirements

Entity mergers and conversions require filing with the Massachusetts Secretary of the Commonwealth, Corporations Division. The Department of Revenue requires tax waivers for asset purchases. Professional corporations require additional filings with the relevant licensing board.

Key Massachusetts Considerations

  • Massachusetts's Noncompetition Agreement Act requires garden leave pay (50% of highest salary in the last 2 years) during the restricted period, making non-compete retention in acquisitions expensive
  • The 4% millionaire surtax (effective 2023) significantly affects after-tax proceeds for high-value deal principals selling pass-through entities
  • Massachusetts has extensive biotech and life sciences tax incentive programs (MLSC) that can affect valuation of acquired entities with qualifying activities

Discuss Your IPO & Going Public Law Needs in Wellesley

Submit your transaction details for a preliminary assessment by our managing partner.

Your information is kept strictly confidential and will never be shared. Privacy Policy

Frequently Asked Questions

Common questions from Wellesley clients

What can I expect during an initial consultation in Wellesley?
During your confidential initial consultation in Wellesley, we'll discuss your ipo & going public law needs, review your current situation, assess potential challenges specific to Massachusetts, and outline a clear path forward. We'll explain our process, answer your questions, and determine if we're the right fit for your needs.
Do you work with companies outside of Wellesley?
Yes, we represent clients nationwide while maintaining a strong presence in Wellesley. Our managing partner handles ipo & going public law matters across all 50 states, coordinating with local counsel where state-specific requirements apply.

Need Specific Guidance?

Submit your transaction details for a preliminary assessment by our managing partner

Submit Transaction Details

IPO & Going Public Law Counsel in Wellesley

Our managing partner provides selective ipo & going public law counsel for transactions nationwide. Submit your transaction details for a preliminary assessment.

Request Engagement Assessment

Submit transaction details for review. We engage selectively with capitalized buyers and sellers.

Your information is kept strictly confidential and will never be shared. Privacy Policy

Selective M&A practice - Nationwide reach - Managing partner on every deal